SpectronRx
IN - IndianapolisCDMO (Contract Manufacturing)
Focus: SpectronRx is a CDMO specializing in diagnostic radiopharmaceuticals and radionuclide-based contract manufacturing, headquartered in Indianapolis. The company focuses on oncology applications with a portfolio of FDA-approved diagnostic agents and early-stage therapeutic programs.
Profile data last refreshed 10h ago · AI intelligence enriched 3w ago
Open Jobs
0
About SpectronRx
AI assessmentNot HiringNo open roles listed right now. Follow SpectronRx to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Declining
Post-LOE
ANDA-approved diagnostic agent post-loss-of-exclusivity; generates revenue through CDMO manufacturing and supply rather than proprietary drug sales.
Help build intelligence for SpectronRx
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.